Skip to main content
. 2004 May;6(3):224–233. doi: 10.1593/neo.3352

Figure 3.

Figure 3

Monitoring the response of human WISH-PC14 xenografts to TOOKAD-based PDT by histological and immunohistochemical examination. Tumors from light control (LC; A), dark control (DC; B), and 7, 24, and 48 hours post-PDT (C, D, and E, respectively) were fixed and stained with hematoxylin and eosin (n = 2 for each one presented in the figure). The same tumors from LC (F), DC (G), and 7, 24, and 48 hours post-PDT (H, I, and J, respectively) were also immunostained for LPO by anti-HNE antibodies. Scale bar = 50 µm.